Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation

ClinicalTrials.gov ID: NCT00804141

Public ClinicalTrials.gov record NCT00804141. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 10:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study to Evaluate the Long-Term Safety of Subcutaneous MOA-728 for Treatment of Opioid-Induced Constipation in Subjects With Nonmalignant Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to evaluate the long-term safety and tolerability of the subcutaneous (SC) injection form of N-methylnaltrexone bromide (MOA-728) for the treatment of opioid-induced constipation in participants with nonmalignant pain. The study consists of a 2-week screening period, a 48-week open-label treatment period and a 2 week follow-up period. Participants will need to agree to self-administer SC injections, complete daily diaries, and check-in via a daily telephone call during the study.

Study identification

NCT ID
NCT00804141
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
1,040 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 3, 2008 (Actual)
Primary completion
Sep 20, 2010 (Actual)
Completion
Sep 20, 2010 (Actual)
Last update posted
Oct 18, 2019

2008 – 2010

United States locations

U.S. sites
94
U.S. states
33
U.S. cities
79
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35242 —
Pfizer Investigational Site Chandler Arizona 85224 —
Pfizer Investigational Site Mesa Arizona 85206 —
Pfizer Investigational Site Mesa Arizona 85213 —
Pfizer Investigational Site Phoenix Arizona 85028 —
Pfizer Investigational Site Phoenix Arizona 85029 —
Pfizer Investigational Site Tempe Arizona 85282 —
Pfizer Investigational Site Tucson Arizona 85710 —
Pfizer Investigational Site Tucson Arizona 85741 —
Pfizer Investigational Site Hot Springs Arkansas 71913 —
Pfizer Investigational Site Garden Grove California 92843 —
Pfizer Investigational Site Laguna Hills California 92653 —
Pfizer Investigational Site Los Gatos California 95032 —
Pfizer Investigational Site Newport Beach California 92660 —
Pfizer Investigational Site Newport Beach California 92663 —
Pfizer Investigational Site Colorado Springs Colorado 80904 —
Pfizer Investigational Site Boca Raton Florida 33432 —
Pfizer Investigational Site Brandon Florida 33511 —
Pfizer Investigational Site Chiefland Florida 32626 —
Pfizer Investigational Site Clearwater Florida 33756 —
Pfizer Investigational Site Daytona Beach Florida 32117 —
Pfizer Investigational Site Fort Myers Florida 33916 —
Pfizer Investigational Site Gainesville Florida 32607 —
Pfizer Investigational Site Jacksonville Florida 32216 —
Pfizer Investigational Site Jacksonville Florida 32257 —
Pfizer Investigational Site Jupiter Florida 33458 —
Pfizer Investigational Site Miami Florida 33180 —
Pfizer Investigational Site Miami Florida 33183 —
Pfizer Investigational Site Ocala Florida 34471-2106 —
Pfizer Investigational Site Ocala Florida 34471 —
Pfizer Investigational Site Ocala Florida 34474 —
Pfizer Investigational Site Orlando Florida 32806 —
Pfizer Investigational Site Ormond Beach Florida 32174 —
Pfizer Investigational Site Port Orange Florida 32129 —
Pfizer Investigational Site Sarasota Florida 34231 —
Pfizer Investigational Site Sarasota Florida 34239 —
Pfizer Investigational Site Tampa Florida 33603 —
Pfizer Investigational Site Tampa Florida 33613 —
Pfizer Investigational Site Vero Beach Florida 32960 —
Pfizer Investigational Site Winter Park Florida 32789 —
Pfizer Investigational Site Chicago Illinois 60616 —
Pfizer Investigational Site Rockford Illinois 61107 —
Pfizer Investigational Site Avon Indiana 46123 —
Pfizer Investigational Site Evansville Indiana 47714 —
Pfizer Investigational Site Indianapolis Indiana 46205 —
Pfizer Investigational Site Indianapolis Indiana 46250 —
Pfizer Investigational Site West Des Moines Iowa 50265 —
Pfizer Investigational Site Madisonville Kentucky 42431 —
Pfizer Investigational Site Hagerstown Maryland 21742 —
Pfizer Investigational Site Hollywood Maryland 20636 —
Pfizer Investigational Site Boston Massachusetts 02115 —
Pfizer Investigational Site Brockton Massachusetts 02301 —
Pfizer Investigational Site Watertown Massachusetts 02472 —
Pfizer Investigational Site Bingham Farms Michigan 48025 —
Pfizer Investigational Site Chesterfield Michigan 48047 —
Pfizer Investigational Site Kalamazoo Michigan 49009 —
Pfizer Investigational Site Traverse City Michigan 49684 —
Pfizer Investigational Site Edina Minnesota 55435 —
Pfizer Investigational Site Biloxi Mississippi 39531 —
Pfizer Investigational Site Jackson Mississippi 39202 —
Pfizer Investigational Site Springfield Missouri 65807 —
Pfizer Investigational Site Omaha Nebraska 68131 —
Pfizer Investigational Site Henderson Nevada 89014 —
Pfizer Investigational Site Las Vegas Nevada 89119 —
Pfizer Investigational Site Las Vegas Nevada 89123 —
Pfizer Investigational Site Las Vegas Nevada 89146 —
Pfizer Investigational Site Elizabeth New Jersey 07202 —
Pfizer Investigational Site Albuquerque New Mexico 87102 —
Pfizer Investigational Site Great Neck New York 11023 —
Pfizer Investigational Site New York New York 10022 —
Pfizer Investigational Site Charlotte North Carolina 28204 —
Pfizer Investigational Site Raleigh North Carolina 27607 —
Pfizer Investigational Site Fargo North Dakota 58103 —
Pfizer Investigational Site Centerville Ohio 45459 —
Pfizer Investigational Site Dayton Ohio 45432 —
Pfizer Investigational Site Oklahoma City Oklahoma 73112 —
Pfizer Investigational Site Medford Oregon 97504 —
Pfizer Investigational Site Portland Oregon 97210 —
Pfizer Investigational Site Altoona Pennsylvania 16602 —
Pfizer Investigational Site Levittown Pennsylvania 19056 —
Pfizer Investigational Site Yardley Pennsylvania 19067 —
Pfizer Investigational Site Cranston Rhode Island 02920 —
Pfizer Investigational Site Huntingdon Tennessee 38344 —
Pfizer Investigational Site Austin Texas 78705 —
Pfizer Investigational Site Beaumont Texas 77701 —
Pfizer Investigational Site Dallas Texas 75230 —
Pfizer Investigational Site Dallas Texas 75234 —
Pfizer Investigational Site Houston Texas 77074 —
Pfizer Investigational Site Hurst Texas 76054 —
Pfizer Investigational Site San Antonio Texas 78215 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site Salt Lake City Utah 84106 —
Pfizer Investigational Site Christiansburg Virginia 24073 —
Pfizer Investigational Site Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00804141, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 18, 2019 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00804141 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →